Patent directory · USPTO A61K / A61P
Patents matching “The Regents of the University of California”
3,494 pharma patents match "The Regents of the University of California" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 3,494 pharmaceutical patents matching "The Regents of the University of California" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 8900862
Mesh enclosed tissue constructs
granted -
US 8895539
Pregnancy hormone combination for treatment of autoimmune diseases
granted -
US 8895242
Single molecule nucleic acid nanoparticles
granted -
US 8895055
Telodendrimer nanodiscs without apolipoprotein
granted -
US 8889638
Stimulus-triggered prodrugs
granted -
US 8889140
Compositions and methods for tissue repair
granted -
US 8889156
Calcium-binding agents induce hair growth and/or nail growth
granted -
US 8889658
Phosphonate compounds
granted -
US 8883214
Implantable delivery vehicle for ocular delivery of muscarinic antagonists
granted -
US 8883502
Expandable cell source of neuronal stem cell populations and methods for obtaining and using them
granted -
US 8883155
Methods for treating hematopoietic malignancies
granted -
US 8877721
Small activating RNA molecules and methods of use
granted -
US 8877195
Monoclonal antibodies to fibrin
granted -
US 8871447
Immunogens and corresponding antibodies specific for high molecular weight aggregation intermediates common to amyloids formed from proteins of differing sequence
granted -
US 8865914
Fluorescent probes for detection of copper
granted -
US 8865469
Methods of transforming a Listeria
granted -
US 8865719
Substituted heterocycles and their use as allosteric modulators of nicotinic and GABAA receptors
granted -
US 8865873
Internalizing human monoclonal antibodies targeting prostate cancer cells in situ
granted -
US 8859520
Methods for therapy of neurodegenerative disease of the brain
granted -
US 8858950
Delivery of pharmaceutical agents via the human insulin receptor
granted -
US 8859499
Method of enhancing efficacy of blood transfusions
granted -
US 8852626
Controlled-release CNS modulating compositions and methods for the treatment of otic disorders
granted -
US 8852447
Porous nanostructures and methods involving the same
granted -
US 8852940
Embryonic stem cell specific microRNAs promote induced pluripotency
granted